Rapid Micro Biosystems, Inc. (RPID)
NASDAQ: RPID · Real-Time Price · USD
2.270
+0.110 (5.09%)
At close: Apr 2, 2026, 4:00 PM EDT
2.350
+0.080 (3.52%)
After-hours: Apr 2, 2026, 7:55 PM EDT
Rapid Micro Biosystems Revenue
In the year 2025, Rapid Micro Biosystems had annual revenue of $33.59M with 19.74% growth. Rapid Micro Biosystems had revenue of $11.28M in the quarter ending December 31, 2025, with 37.28% growth.
Revenue (ttm)
$33.59M
Revenue Growth
+19.74%
P/S Ratio
3.07
Revenue / Employee
$196,415
Employees
171
Market Cap
103.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 33.59M | 5.54M | 19.74% |
| Dec 31, 2024 | 28.05M | 5.53M | 24.57% |
| Dec 31, 2023 | 22.52M | 5.39M | 31.44% |
| Dec 31, 2022 | 17.13M | -6.10M | -26.25% |
| Dec 31, 2021 | 23.23M | 7.16M | 44.50% |
| Dec 31, 2020 | 16.08M | -435.00K | -2.63% |
| Dec 31, 2019 | 16.51M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Treace Medical Concepts | 212.69M |
| Neuronetics | 149.16M |
| Outset Medical | 119.48M |
| Owlet | 105.71M |
| AVITA Medical | 71.61M |
| LENSAR | 58.44M |
| SANUWAVE Health | 44.05M |
| MaxCyte | 33.03M |
RPID News
- 21 days ago - Rapid Micro Biosystems: Big Pharma Adoption Driving Growth - Seeking Alpha
- 22 days ago - Rapid Micro Biosystems, Inc. (RPID) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Rapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance - GlobeNewsWire
- 22 days ago - Rapid Micro Biosystems Announces Follow-on Multi-System Order from Samsung Biologics to Expand Deployment of Growth Direct® Platform - GlobeNewsWire
- 23 days ago - Rapid Micro Biosystems to Participate in KeyBanc Capital Markets Healthcare Forum - GlobeNewsWire
- 5 weeks ago - Rapid Micro Biosystems to Present at TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 5 weeks ago - Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 - GlobeNewsWire
- 7 weeks ago - Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire